NanoMab Conducting Study of Lantheus's PD-L1 Imaging Agent
The trial will evaluate how well the NM-01 radiotracer identifies NSCLC patients with PD-L1-expressing tumors who can benefit from checkpoint inhibitors.
Stay updated with breaking news from Gary Cook. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The trial will evaluate how well the NM-01 radiotracer identifies NSCLC patients with PD-L1-expressing tumors who can benefit from checkpoint inhibitors.
The trial will evaluate how well the NM-01 radiotracer identifies NSCLC patients with PD-L1-expressing tumors who can benefit from checkpoint inhibitors.
A new report has ranked 230 global multinational companies on their efforts to reduce carbon emissions from corporate travel.
POLITICAL point-scoring by Labour is putting jobs at the embattled shipyard at the heart of the ferries debacle, a trade union has warned.
WHILE investors appear keen to build huge windfarms off Scotland, hopes that such projects will generate lots of jobs in the country dimmed last…